UNBELIEVABLE: Resmed earnings preview what to expect - Caught on Camera

ResMed Inc. (RMD), headquartered in San Diego, California, develops, manufactures, distributes, and markets medical devices and cloud-based software applications for healthcare. Valued at $30.78 billion by market cap, the company’s digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, and other chronic diseases. The medical equipment company is expected to announce its fiscal fourth-quarter earnings for 2024 after the market closes on Thursday, Aug. 1. 

Ahead of the event, analysts expect RMD to report a profit of $2.02 per share on a diluted basis, up 26.3% from $1.60 per share in the year-ago quarter. The company beat the consensus estimates in three of the last four quarters while missing on another occasion. During the previous quarter, RMD launched the AirFit F40 mask system, combined with its entire portfolio of products, software, and solutions. It also paid $70 million in dividends and repurchased 261,000 shares.